Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6800
+1.6799 (1679900.00%)
NASDAQ· Last Trade: Jun 17th, 8:17 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors